Literature DB >> 2296577

Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.

L K Tan1, R J Shopes, V T Oi, S L Morrison.   

Abstract

We have characterized a series of genetically engineered chimeric human IgG3 and IgG4 anti-dansyl (DNS) antibodies with identical antibody-combining sites but different hinge region amino acid compositions to determine how the hinge region influences Fab fragment segmental flexibility, C1q binding, and complement activation. Our data support the correlation between "upper hinge" length and Fab segmental flexibility; moreover, we confirm that a hinge region is essential for C1q binding and complement activation. However, the hinge length by itself is not sufficient for complement activity in IgG molecules. We have demonstrated that the IgG4 hinge, which imparts restricted segmental flexibility, reduces the ability of IgG3 molecules to activate complement. We also find that the IgG3 hinge region, which imparts greater segmental motion, is not sufficient to create complement activation activity in IgG4 anti-DNS antibodies. Finally, we conclude that (i) segmental motion is correlated with "upper hinge" length, (ii) hinge length and segmental flexibility is not enough to alter complement binding and activation, and (iii) segmental flexibility does not correlate with proficiency to activate the complement cascade.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296577      PMCID: PMC53220          DOI: 10.1073/pnas.87.1.162

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Amino acid sequence of a murine immunoglobulin fragment that possesses complement fixing activity.

Authors:  J M Kehoe; A Bourgois; J D Capra; M Fougereau
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

2.  The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1.

Authors:  D Yasmeen; J R Ellerson; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

Review 3.  Structure and function of the constant regions of immunoglobulins.

Authors:  D Beale; A Feinstein
Journal:  Q Rev Biophys       Date:  1976-05       Impact factor: 5.318

Review 4.  Immunoglobulin G: functional sites.

Authors:  D R Burton
Journal:  Mol Immunol       Date:  1985-03       Impact factor: 4.407

5.  The monocyte binding domain(s) on human immunoglobulin G.

Authors:  J M Woof; M I Nik Jaafar; R Jefferis; D R Burton
Journal:  Mol Immunol       Date:  1984-06       Impact factor: 4.407

6.  Correlation between segmental flexibility and effector function of antibodies.

Authors:  V T Oi; T M Vuong; R Hardy; J Reidler; J Dangle; L A Herzenberg; L Stryer
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

7.  Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region.

Authors:  M Klein; N Haeffner-Cavaillon; D E Isenman; C Rivat; M A Navia; D R Davies; K J Dorrington
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Rotational dynamics of monoclonal anti-dansyl immunoglobulins.

Authors:  J Reidler; V T Oi; W Carlsen; T M Vuong; I Pecht; L A Herzenberg; L Stryer
Journal:  J Mol Biol       Date:  1982-07-15       Impact factor: 5.469

9.  Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement.

Authors:  M Colomb; R R Porter
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

10.  The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.

Authors:  D E Isenman; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

View more
  28 in total

1.  Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses.

Authors:  N McCloskey; M W Turner; P Steffner; R Owens; D Goldblatt
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies.

Authors:  M S Chappel; D E Isenman; M Everett; Y Y Xu; K J Dorrington; M H Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment.

Authors:  D J King; J R Adair; S Angal; D C Low; K A Proudfoot; J C Lloyd; M W Bodmer; G T Yarranton
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

4.  Intrachain disulfide bond in the core hinge region of human IgG4.

Authors:  J W Bloom; M S Madanat; D Marriott; T Wong; S Y Chan
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

5.  The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen.

Authors:  Ivan Correia; Joyce Sung; Randall Burton; Clarissa G Jakob; Bridget Carragher; Tariq Ghayur; Czeslaw Radziejewski
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

6.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 7.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

8.  Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein.

Authors:  Rosendo Luria-Pérez; Pierre V Candelaria; Tracy R Daniels-Wells; José A Rodríguez; Gustavo Helguera; Manuel L Penichet
Journal:  Cytokine       Date:  2019-05-20       Impact factor: 3.861

9.  Targeting of functional antibody-CD59 fusion proteins to a cell surface.

Authors:  H F Zhang; J Yu; E Bajwa; S L Morrison; S Tomlinson
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.

Authors:  S Martin; J M Casasnovas; D E Staunton; T A Springer
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.